Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX) shares traded 4.39% higher at $6.42 on Wall Street last session.
BCRX stock price is now 15.74% away from the 50-day moving average and 11.24% away from the 200-day moving average. The market capitalization of the company currently stands at $1.32B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
On September 18, 2023, RBC Capital Mkts Upgraded its previous ‘Sector Perform’ rating to ‘Outperform’ on the stock increasing its target price from $9 to quote $10, while ‘Jefferies’ rates the stock as ‘Buy’
In other news, SANDERS MACHELLE, Director sold 4,689 shares of the company’s stock on Jun 17 ’24. The stock was sold for $28,134 at an average price of $6.00. Upon completion of the transaction, the Director now directly owns 27,742 shares in the company, valued at $0.18 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Jun 14 ’24, Director HEGGIE THERESA sold 6,698 shares of the business’s stock. A total of $40,925 was realized by selling the stock at an average price of $6.11. This leaves the insider owning 52,852 shares of the company worth $0.34 million. A total of 4.03% of the company’s stock is owned by insiders.
During the past 12 months, Biocryst Pharmaceuticals Inc. has had a low of $4.03 and a high of $7.95. The fifty day moving average price for BCRX is $5.5778 and a two-hundred day moving average price translates $5.76835 for the stock.
The latest earnings results from Biocryst Pharmaceuticals Inc. (NASDAQ: BCRX) was released for 2024-03-31. The company reported revenue of $92.76 million for the quarter, compared to $68.78 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 34.87 percent.
